Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06671652 · ClinicalTrials.gov registry record · NA

Adaptation and Implementation of a Cherokee-based Participatory Research Project to Reduce CVD Risk

A NA study of Blood Pressure, sponsored by University of Missouri-Columbia.

Completed
Registry status
NA
Development phase
42
Enrollment target
1
Study location

NCT06671652 is a NA study of Blood Pressure that has completed, run by University of Missouri-Columbia. The registered enrollment target is 42 participants, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06671652, a NA study of Blood Pressure, has completed, sponsored by University of Missouri-Columbia.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

This is a two phase project. Phase I is an online convenience sample to collect health and preference data for the intervention phase, as well as a partnership with community to co-create an intervention; Phase II. Phase II is an intervention to improve community connection and historical knowledge within Cherokee communities within the Cherokee Nation reservation involving consultation with Cherokee cultural and historical experts.

Conditions Studied

Interventions

  • BEHAVIORAL Duyugoda igalenisodi (Starting again the right way)

Study Locations (1)

Oklahoma

  • Cherokee Nation - Tahlequah

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2023-09-24
Est. Completion 2024-06-01
Phase NA

Sponsor

University of Missouri-Columbia

291 total trials

What the Registry Record Tells You About NCT06671652

The ClinicalTrials.gov registry entry for NCT06671652 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (85% lower). The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which Duyugoda igalenisodi (Starting again the right way) is the first listed.

NCT06671652 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT06671652 about?

NCT06671652 is a clinical study titled "Adaptation and Implementation of a Cherokee-based Participatory Research Project to Reduce CVD Risk". This is a two phase project. Phase I is an online convenience sample to collect health and preference data for the intervention phase, as well as a partnership with community to co-create an intervention; Phase II. Phase II is an intervention to improve community connection and historical knowledge ...

What is the current status of trial NCT06671652?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2023-09-24. Estimated completion is 2024-06-01.

What conditions does trial NCT06671652 study?

This clinical trial studies the following conditions: Blood Pressure.

What interventions are being tested in trial NCT06671652?

The interventions under investigation include: Duyugoda igalenisodi (Starting again the right way) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06671652?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06671652 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.